Search research articles
Contact Us
Filters
Showing results (1-10 of 18) with videos related to
Page
of 2
Sort By:
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
December 11, 2012
Maximal endurable time states and the standard gamble: more preference reversals
P F M Stalmeier, A L Verheijen
Pharmacoeconomics
|
May 22, 2014
The better than dead method: feasibility and interpretation of a valuation study
R A van Hoorn, A R T Donders, M Oppe, et al.
Health Economics
|
June 21, 2006
The Dutch tariff: results and arguments for an effective design for national EQ-5D valuation studies
L M Lamers, J McDonnell, P F M Stalmeier, et al.
Nederlands Tijdschrift Voor Geneeskunde
|
July 26, 2005
[Measuring the quality of life in economic evaluations: the Dutch EQ-5D tariff]
L M Lamers, P F M Stalmeier, J McDonnell, et al.
The British Journal of Dermatology
|
April 11, 2016
Valuation of pemphigus vulgaris and pemphigus foliaceus health states: a convenience sample experiment
F Rencz, V Brodszky, P F M Stalmeier, et al.
Human Reproduction Open
|
August 5, 2022
Women's preferences concerning IVF treatment: a discrete choice experiment with particular focus on embryo transfer policy
S Cornelisse, M S Vos, H Groenewoud, et al.
Preventive Medicine
|
May 27, 2005
Do patients' preferences predict smoking cessation?
L C W Wiggers, P F M Stalmeier, F J Oort, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
December 29, 2012
TIPP and Lichtenstein modalities for inguinal hernia repair: a cost minimisation analysis alongside a randomised trial
G G Koning, E M M Adang, P F M Stalmeier, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
July 3, 2019
Patient-assigned health utility values for controlled and uncontrolled pemphigus vulgaris and foliaceus
K Hajdu, V Brodszky, P F M Stalmeier, et al.
British Journal of Cancer
|
December 17, 2003
Palliative chemotherapy or best supportive care? A prospective study explaining patients' treatment preference and choice
C G Koedoot, R J de Haan, A M Stiggelbout, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 18) with videos related to
Sort By:
Page
of 2
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
December 11, 2012
Maximal endurable time states and the standard gamble: more preference reversals
P F M Stalmeier, A L Verheijen
Pharmacoeconomics
|
May 22, 2014
The better than dead method: feasibility and interpretation of a valuation study
R A van Hoorn, A R T Donders, M Oppe, et al.
Health Economics
|
June 21, 2006
The Dutch tariff: results and arguments for an effective design for national EQ-5D valuation studies
L M Lamers, J McDonnell, P F M Stalmeier, et al.
Nederlands Tijdschrift Voor Geneeskunde
|
July 26, 2005
[Measuring the quality of life in economic evaluations: the Dutch EQ-5D tariff]
L M Lamers, P F M Stalmeier, J McDonnell, et al.
The British Journal of Dermatology
|
April 11, 2016
Valuation of pemphigus vulgaris and pemphigus foliaceus health states: a convenience sample experiment
F Rencz, V Brodszky, P F M Stalmeier, et al.
Human Reproduction Open
|
August 5, 2022
Women's preferences concerning IVF treatment: a discrete choice experiment with particular focus on embryo transfer policy
S Cornelisse, M S Vos, H Groenewoud, et al.
Preventive Medicine
|
May 27, 2005
Do patients' preferences predict smoking cessation?
L C W Wiggers, P F M Stalmeier, F J Oort, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
December 29, 2012
TIPP and Lichtenstein modalities for inguinal hernia repair: a cost minimisation analysis alongside a randomised trial
G G Koning, E M M Adang, P F M Stalmeier, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
July 3, 2019
Patient-assigned health utility values for controlled and uncontrolled pemphigus vulgaris and foliaceus
K Hajdu, V Brodszky, P F M Stalmeier, et al.
British Journal of Cancer
|
December 17, 2003
Palliative chemotherapy or best supportive care? A prospective study explaining patients' treatment preference and choice
C G Koedoot, R J de Haan, A M Stiggelbout, et al.
Page
of 2